Source: International Congress 2015 – Non-exhaled biomarkers in the assessment of airways disease
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Hanine Al Kayal (Machghara, West Bekaa, Lebanon), Hanine Al Kayal, Hassan Abu Bass, Ahmad El Sabbah, Wiam Ramadan, Hassan Khachfe, Khalil Al Kwatly, Wissam H. Joumaa. Can HSP27 and HSP70 be used as biomarkers for chronic obstructive pulmonary disease diagnosis?. Eur Respir J 2015; 46: Suppl. 59, 3971

Member's Comments

No comment yet.

Related content which might interest you: Pentraxin 3 as a novel biomarker of inflammation in chronic obstructive pulmonary disease Source: Annual Congress 2013 –Systemic and airway biomarkers in respiratory diseases Year: 2013 Biomarkers in the management of COPD Source: Eur Respir Rev 2009; 18: 96-104 Year: 2009 Identification of oxidative stress markers and their association with inflammation in smokers and early chronic obstructive pulmonary disease (COPD) Source: International Congress 2016 – Hospitalisation and comorbidities in chronic lung diseases Year: 2016 The prognostic importance of the protease-antiprotease imbalance in development of chronic obstructive pulmonary disease comorbid with chronic pancreatitis Source: International Congress 2015 – COPD: exacerbations, gas exchange and associated dysfunction Year: 2015 Elevated sputum BPIFB1 levels correlate with progression of chronic obstructive pulmonary disease Source: International Congress 2015 – Exploring mechanisms in obstructive airway diseases Year: 2015 Association between adipokines, inflammatory markers and systemic manifestations in chronic obstructive pulmonary disease (COPD) patients Source: International Congress 2016 – Biomarkers and phenotypes of COPD and comorbidities Year: 2016 Peripheral neuropathy in chronic obstructive pulmonary disease Source: International Congress 2014 – Comorbidities Year: 2014 The characteristic of chronic renal dysfunction in patients with chronic obstructive pulmonary disease Source: International Congress 2016 – Biomarkers and phenotypes of COPD and comorbidities Year: 2016 Evaluation of fatigue state with virus-related novel biomarkers in obstructive lung diseases Source: International Congress 2016 – Notable abstracts on clinical problems related to asthma Year: 2016 Potential biomarkers in patients with chronic obstructive pulmonary disease (COPD) Source: Virtual Congress 2020 – Mechanistic insight into lung injury and repair Year: 2020 Inflammatory biomarkers and comorbidities in chronic obstructive pulmonary disease Source: Annual Congress 2012 - Asthma and COPD: quality of life and comorbidities Year: 2012 Chronic obstructive pulmonary disease: phenotyping and differential diagnosis Source: International Congress 2018 – Imaging Grand Round Year: 2018 Prognostic value of C-reactive protein in patients with severe to very severe chronic obstructive pulmonary disease Source: Annual Congress 2006 - COPD and inflammation Year: 2006 Study of inflammatory markers and BODE index in patients with chronic obstructive pulmonary disease Source: International Congress 2016 – Systemic biomarkers Year: 2016 Prediction of chronic renal failure in patients with chronic obstructive pulmonary disease Source: International Congress 2014 – COPD: points to ponder Year: 2014 Some gender features of the chronic obstructive pulmonary disease Source: Annual Congress 2013 –COPD treatment Year: 2013 Detection of chronic obstructive pulmonary disease (COPD) in patients with cardio-vascular system pathology Source: Annual Congress 2013 –COPD treatment and others Year: 2013 Can ADMA play a role in determining pulmonary hypertension related to chronic obstructive lung disease? Source: International Congress 2016 – Pulmonary hypertension in lung disease Year: 2016 Investigation of the role of miRNAs as a biomarker in chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2012 - COPD inflammation and genes Year: 2012 Anemia in patients with chronic obstructive pulmonary disease - Association with comorbidities Source: International Congress 2016 – Hospitalisation and comorbidities in chronic lung diseases Year: 2016